Vimeo
LinkedIn
Instagram
Share |

Ownership and Management

March 17, 2023

In an exclusive interview with Campden FB, Dr. David Brown talks about his passion for entrepreneurialism, the mind-blowing benefits of machine learning and how big pharma needs a change in mindset…

Throughout his storied career, Dr. David Brown has made significant contributions to medical research within the pharmaceutical industry, but perhaps his most famous innovation came about through a chance observation when the angina medication he was working on had unexpected applications.

While working for Pfizer, he was named co-inventor on the patent for Viagra and, for eight years, led the team that developed the hugely successful erectile dysfunction medication into one of the bonanza breakthroughs of the century.

March 13, 2023

In this week’s FB Roundup, L’Oreal heir Francoise Bettencourt Meyers names new investment firm MD; Klaus-Michael Kuehne is to receive $4.5 billion dividends from his transport empire; and tributes are paid to 7-Eleven billionaire Masatoshi Ito.

L’Oreal heir Francoise Bettencourt Meyers names new investment firm MD
The world’s richest woman, Francoise Bettencourt Meyers, has named Cyrielle Villepelet as managing director of her investment company, Tethys Invest, according to Bloomberg.

March 8, 2023

In this week’s FB Roundup, the Spanish prime minister speaks out against Rafael del Pino Jr’s headquarters move; Goldman Sachs joins the bid to buy Subway from founders’ heirs; and tributes are paid to US truck stop chain founder Tom Love.

Spanish prime minister speaks out against Rafael del Pino Jr.’s headquarters move
Spanish prime minister Pedro Sánchez has publicly criticised billionaire businessman Rafael del Pino Jr. after revealing plans to move the headquarters of Ferrovial SA to the Netherlands.

March 8, 2023

Private Equity is mainstream among ultra-high-net-worth (94% engaged), with the bulk looking for enhanced returns (67%).

According to The Ultra-High Net Worth Private Equity Investing Report 2023 by Campden Wealth and Titanbay, 84% of ultra-high-net-worth (UHNW) investors hold private equity investments, with a further 10% interested in the asset class.

March 7, 2023

Sooner or later, all privately-owned companies have to tackle the quandary of the generational handover, but is it better to keep it in the family or bring in fresh blood, asks Jesús Rico, professor of strategy at EAE Business School?

Sooner or later, all large family companies have to tackle the quandary of the generational handover. Should they appoint a member of the family who knows the company and has its mission imprinted on their DNA? Or is it better to bring on board a director from outside the company who shakes things up with a new vision?

March 3, 2023

Some younger family members aren’t waiting for formal transitions. They’re focused on contributing today to a world that will still be sustainable in 100 years' time, says KPMG's Creagh Sudding.

There are widespread and ongoing discussions among family businesses about thepotential roles and contributions of next-generation family members. In some cases, this is the result of impending succession decisions and the need for a smooth transition from one generation to the next. But, in other cases, younger family members aren’t waiting for formal transitions. They’re focused on contributing today to aworld that will still be sustainable in 100 years' time.

February 27, 2023

In an exclusive interview with Campden FB, 19th-Generation family member George Muthoot George of the Muthoot Group talks about living up to family legacy, a passion for hospitality and the ultimate motivation for sustainable investment…

For nearly 800 years, the Muthoot family have been heavily involved in business and philanthropy in and around Kerala, India. Since its formal establishment in 1887, the Muthoot Group has grown into multi-layered conglomerate focussing on financial services, healthcare, agriculture, housing, media, education and more.

February 23, 2023

Dr. Richard Orlando discusses the invisible glue that holds families together and how that can affect the success or failure of a family business.

For anyone who has worked with (or in) family businesses for any meaningful period of time, especially as it pertains to continuity planning engagements, they would have heard family members say something like:

February 16, 2023

A beneficiary of the sale of her family’s multi-generational pharmaceutical companies, Victoria Engelhorn was determined to take the opportunity to grow, realise her own dreams and give back to society. In an exclusive interview with Campden FB, she reveals how forging her own socially responsible path gave her meaning and purpose.

The granddaughter of billionaire German businessman Curt Engelhorn, great-great granddaughter of Friedrich Engelhorn (the founder of chemical giant BASF) and the beneficiary of a family-wide windfall, Victoria Engelhorn understands all too well the heft and privilege of inheriting great wealth.

Click here >>
Close